Structured Summary
Abstract
A complex structure that includes isoquinolines joined by a cyclic ester; it is a DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA, after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- ET 743
- ET-743
- Ecteinascidin 743
- NSC 684766
- Yondelis
- ET743
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2019 (1996)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Trabectedin. Medical Subject Headings (MeSH). 2026. Unique ID D000077606. http://id.nlm.nih.gov/mesh/2026/D000077606
- Trabectedin. In: Wikipedia. https://en.wikipedia.org/wiki/Trabectedin
- Trabectedin. In: Wikidata. https://www.wikidata.org/wiki/Q2637746